Ana Rita Torres

Ana Rita Torres

Auto-generated profile, based on publicly available information

Ana Rita Torres

European Centre for Disease Prevention and Control, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Eurosurveillance
Verified
Journal Article
Open access
ATAna Rita Torres
Ana Rita Torres
ARAna Paula Rodrigues
Ana Paula Rodrigues
MSMafalda Sousa-Uva
Mafalda Sousa-Uva
IKIrina Kislaya
Irina Kislaya
SSSusana Silva
Susana Silva
BNBaltazar Nunes
Baltazar Nunes
Background: Non-pharmaceutical interventions (NPIs) were implemented worldwide to control the spread of SARS-CoV-2. Aim: To evaluate the impact of tiered NPIs and a nationwide lockdown on reduction of COVID-19 incidence during the second and third epidemic waves in Portugal. Methods: Surveillance data on laboratory-confirmed COVID-19 cases were used to conduct an interrupted time series analysis to estimate changes in daily incidence during a second wave tiered NPI period (9 November–18 December 2020), and a third wave lockdown period without (15–21 January 2021) and with school closure (22 January–10 February 2021). Results: Significant changes in trends were observed for the overall incidence rate; declining trends were observed for tiered NPIs (−1.9% per day; incidence rate ratio (IRR): 0.981; 95% confidence interval (CI): 0.973–0.989) and a lockdown period without (−3.4% per day; IRR: 0.966; 95% CI: 0.935–0.998) and with school closure (−10.3% per day, IRR: 0.897; 95% CI: 0.846–0.951). Absolute effects associated with tiered NPIs and a lockdown on a subsequent 14-day period yielded 137 cases and 437 cases per 100,000 population potentially averted, respectively. Conclusion: Our results indicate that tiered NPIs implemented during the second wave caused a decline in COVID-19 incidence, although modest. Moreover, a third wave lockdown without school closure was effective in reducing COVID-19 incidence, but the addition of school closure provided the strongest effect. These findings emphasise the importance of early and assertive decision-making to control the pandemic.

1 January 2023 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
PDF file
ATAna Rita Torres
Ana Rita Torres
VGVerónica Gómez
Verónica Gómez
IKIrina Kislaya
Irina Kislaya
ARAna Paula Rodrigues
Ana Paula Rodrigues
MTMargarida Fernandes Tavares
Margarida Fernandes Tavares
AMAusenda Cristina Nelson Machado
Ausenda Cristina Nelson Machado
Background. Severe acute respiratory infections (SARI) surveillance is recommended to assess the severity of respiratory infections disease. In 2021, the National Institute of Health Doutor Ricardo Jorge, in collaboration with two general hospitals, implemented a SARI sentinel surveillance system based on electronic health registries. We describe its application in the 2021/2022 season and compare the evolution of SARI cases with the COVID‐19 and influenza activity in two regions of Portugal. Methods. The main outcome of interest was the weekly incidence of patients hospitalized due to SARI, reported within the surveillance system. SARI cases were defined as patients containing ICD‐10 codes for influenza‐like illness, cardiovascular diagnosis, respiratory diagnosis, and respiratory infection in their primary admission diagnosis. Independent variables included weekly COVID‐19 and influenza incidence in the North and Lisbon and Tagus Valley regions. Pearson and cross‐correlations between SARI cases, COVID‐19 incidence and influenza incidence were estimated. Results. A high correlation between SARI cases or hospitalizations due to respiratory infection and COVID‐19 incidence was obtained (ρ = 0.78 and ρ = 0.82, respectively). SARI cases detected the COVID‐19 epidemic peak a week earlier. A weak correlation was observed between SARI and influenza cases (ρ = −0.20). However, if restricted to hospitalizations due to cardiovascular diagnosis, a moderate correlation was observed (ρ = 0.37). Moreover, hospitalizations due to cardiovascular diagnosis detected the increase of influenza epidemic activity a week earlier. Conclusion. In the 2021/2022 season, the Portuguese SARI sentinel surveillance system pilot was able to early detect the COVID‐19 epidemic peak and the increase of influenza activity. Although cardiovascular manifestations associated with influenza infection are known, more seasons of surveillance are needed, to confirm the potential use of cardiovascular hospitalizations as an indicator of influenza activity.

13 January 2022 in Infectious Diseases
Verified
Journal Article
Closed access
IKIrina Kislaya
Irina Kislaya
PGPaulo Gonçalves
Paulo Gonçalves
VGVerónica Gómez
Verónica Gómez
VGVânia Gaio
Vânia Gaio
RRRita Roquette
Rita Roquette
OGon Behalf of ISN2COVID-19 Group
on Behalf of ISN2COVID-19 Group
Integrated approaches to surveillance of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection are important for public health actions. The 2nd National Serological Survey (ISN2COV...

10 July 2025 in Eurosurveillance
Verified
Journal Article
Open access
MRMiguel Angel Sanchez Ruiz
Miguel Angel Sanchez Ruiz
DMDiogo Fp Marques
Diogo Fp Marques
FLFrederikke Kristensen Lomholt
Frederikke Kristensen Lomholt
LVLasse Skafte Vestergaard
Lasse Skafte Vestergaard
SMSusana Monge
Susana Monge
BNBaltazar Nunes
Baltazar Nunes
BACKGROUND: Surveillance of severe acute respiratory infections (SARI) using ICD-10 codes from electronic health records (EHR) lacks consensus on optimal case-defining codes. AIM: We determined codes that maximise sensitivity (Se) and positive predictive value (PPV) for SARI associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), influenza virus and respiratory syncytial virus (RSV) in Denmark, Iceland, Malta, Norway and Spain. METHODS: We included hospitalisations from week 21/2021 to 39/2023, with ICD-10 diagnostic codes for respiratory disease (three-character codes J00–J99) or COVID-19 (U07.1, U07.2, country-specific codes for Denmark). We assessed Se and PPV of individual codes against laboratory results. Based on Se and PPV rank-sum, we selected the top 10 codes and combined them into 10 sets per pathogen. We identified sets that maximised the clinical utility index (CUI = Se × PPV), categorised as excellent (≥ 0.81), good (0.64–0.80), satisfactory (0.49–0.63) and poor (< 0.49). RESULTS: We assessed 395,163 hospitalisations for SARI-SARS-CoV-2, 313,418 for SARI-influenza and 192,936 for SARI-RSV, all tested. For SARI-SARS-CoV-2, code U07.1 (B34.2A, B97.2A for Denmark) had excellent utility in Denmark, Malta, Norway, Spain (≥ 0.82), and good utility in Iceland (0.79). For SARI-influenza, J09, J10 and J11 performed excellently in Denmark, Norway, Spain (≥ 0.83), satisfactorily in Malta (0.52), and poorly in Iceland (0.43). For SARI-RSV, J12, J20 and J21 achieved highest CUI but had poor utility (0.17–0.34). CONCLUSIONS: COVID-19- and influenza-specific three-character ICD-10 codes accurately identified SARI associated with SARS-CoV-2 and influenza virus. For SARI-RSV, four-character codes should be explored. We recommend context-specific assessments in countries adopting EHR-based surveillance.

15 November 2023 in Human Vaccines & Immunotherapeutics
Verified
Journal Article
Open access
IKIrina Kislaya
Irina Kislaya
ATAna Rita Torres
Ana Rita Torres
LGLicínia Gomes
Licínia Gomes
AMAryse Melo
Aryse Melo
AMAusenda Cristina Nelson Machado
Ausenda Cristina Nelson Machado
NNNational Influenza Surveillance Network
National Influenza Surveillance Network
Using a test-negative case-control design, we aim to estimate influenza vaccine effectiveness (VE) against medically attended laboratory-confirmed influenza in Portugal in 2022/2023 season. Between week 41/2022 and week 14/2023, data on 592 patients with influenza-like illness aged 18 or more years old were collected by the national sentinel influenza surveillance system in primary care settings. Of those, 218 were positive for influenza and 374 were negative controls. We estimated seasonal influenza VE as (1-odds ratio)*100% of being vaccinated in laboratory-confirmed influenza cases vs. negative controls using logistic regression model adjusted for age group, sex, presence of chronic conditions, and month of symptoms onset. The seasonal VE was 59.3% (95% confidence interval (CI): 27.3 to 77.3) against any laboratory-confirmed influenza and not statistically significant 44.5% (95% CI: -5.6 to 70.8) against influenza A (H3N2). In the 2022/2023 season, characterized by early and low influenza activity and predominant A (H3N2) circulation, vaccination provided a moderate protection against medically attended laboratory-confirmed influenza in primary care.

1 April 2021 in Disability and Health Journal
Verified
Journal Article
Closed access
JSJoana Raquel Raposo dos Santos
Joana Raquel Raposo dos Santos
ATAna Rita Cascão Torres
Ana Rita Cascão Torres
MNMariana Neto
Mariana Neto
SNSónia Namorado
Sónia Namorado